Stockreport

Sinaptica Completes Scientific Advisory Board with Final Expert Appointment as Company Advances to Pivotal Trial in Alzheimer's [Yahoo! Finance]

Longboard Pharmaceuticals, Inc.  (LBPH) 
PDF SAB will help guide the company's Phase 3 clinical development plans based on unprecedented Phase 2 data in Alzheimer's showing 80% disease slowing on cognitive & funct [Read more]